ALHYG.PA
Hybrigenics Société Anonyme [ALHYG.PA] Stock Forecast
Buy or Sell ? Support and Resistance
What is MACD and how to read it?
How RSI can help?
RSI : 000
ALHYG.PA Stock Summary
In the News
ALHYG.PA Financial details
Company Rating
-
Market Cap
4.74M
Income
-600K
Revenue
0
Book val./share
-
Cash/share
-
Dividend
-
Dividend %
-
Employees
17
Optionable
No
Shortable
Yes
Earnings
30 Jun 2019
P/E
-10.01
Forward P/E
-
PEG
-
P/S
4789.8
P/B
0.55
P/C
-
P/FCF
-0.97
Quick Ratio
0.22
Current Ratio
1.73
Debt / Equity
-
LT Debt / Equity
-
-
-
EPS (TTM)
-0
EPS next Y
-
EPS next Q
-
EPS this Y
-
EPS next Y
-
EPS next 5Y
-
EPS last 5Y
-59.38%
Revenue last 5Y
-54.12%
Revenue Q/Q
-
EPS Q/Q
-
-
-
-
-
SMA20
-
SMA50
-
SMA100
-
Inst Own
-
Inst Trans
-
ROA
-4%
ROE
-6%
ROC
-0.05%
Gross Margin
100%
Oper. Margin
-37830%
Profit Margin
-36126%
Payout
-
Shs Outstand
-
Shs Float
-
-
-
-
-
Target Price
-
52W Range
0.0115-0.0699
52W High
-
52W Low
-
RSI
50
Rel Volume
2.08
Avg Volume
2.29M
Volume
-
Perf Week
-
Perf Month
-
Perf Quarter
-
Perf Half Y
-
-
-
-
-
Beta
1.07912
-
-
Volatility
0%, 0%
Prev Close
-
Price
-
Change
-
Company Profile
- Volume Average 2.29M
- Market Capitalization 4.74M
- Employee 17
- CEO Léone Atayi
- Headquarters Gallargues-le-Montueux,FR
- IPO Date 2007-12-28
-
Website
https://www.hybrigenics.com 
Hybrigenics SA, together with its subsidiaries, operates as a biotechnology company in France. The company engages in development of biotechnology in the field of biotechnology, oncology, regenerative medicine, and anti-aging medicine. It is also involved in the development of technical solutions using adipose tissue cells and stem cells. The company is headquartered in Gallargues-le-Montueux, France. Hybrigenics SA is a subsidiary of Diagnostic Medical Systems S.A.
